Insider · CIK 0001357522
Peter A. Thompson
Files at: SION, SPRY, EWTX, CRVS, ALPN, THOR, PRNB, ADAP and 2 more. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 SForm 4 → | Jul 9, 4:47 pm EDT | Sionna Therapeutics, Inc.SION | 85,918 | $44.86 | $3,854,281 | 2,469,959 | −3.36% | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:45 pm EDT | Sionna Therapeutics, Inc.SION | 115,844 | $45.50 | $5,270,902 | 2,555,877 | −4.34% | 10b5-1 |
| Jan 18, 2019 PForm 4 → | Jan 23, 6:01 pm EST | ALPINE IMMUNE SCIENCES, INC.ALPN | 372,439 | $5.37 | $1,999,997 | 3,670,955 | +11.3% | plan? |
| Dec 11, 2018 PForm 4 → | Dec 13, 6:37 pm EST | Synthorx, Inc.THOR | 1,363,636 | $11.00 | $14,999,996 | 5,316,355 | +34.5% | plan? |
| Dec 11, 2018 CForm 4 → | Dec 13, 6:37 pm EST | Synthorx, Inc.THOR | 3,952,719 | — | — | 3,952,719 | — | plan? |
| Jun 4, 2018 SForm 4 → | Jun 6, 6:16 pm EDT | Adaptimmune Therapeutics PLCADAP | 18,700 | $13.56 | $253,631 | 4,901,310 | −0.38% | plan? |
| May 30, 2018 SForm 4 → | Jun 1, 5:27 pm EDT | Adaptimmune Therapeutics PLCADAP | 171,000 | $13.51 | $2,310,420 | 4,920,010 | −3.36% | plan? |
| May 14, 2018 SForm 4 → | May 16, 5:26 pm EDT | Adaptimmune Therapeutics PLCADAP | 10,300 | $13.50 | $139,050 | 5,091,010 | −0.20% | plan? |
| Mar 27, 2018 SForm 4 → | Mar 29, 6:58 pm EDT | Adaptimmune Therapeutics PLCADAP | 1,048,067 | $11.50 | $12,053,730 | 5,101,310 | −17.0% | plan? |
| Mar 12, 2018 PForm 4 → | Mar 14, 2:05 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 588,235 | $8.50 | $4,999,998 | 5,967,584 | +10.9% | plan? |
| Jul 24, 2017 AForm 4 → | Jul 26, 5:20 pm EDT | ALPINE IMMUNE SCIENCES, INC.ALPN | 3,298,516 | — | — | 3,298,516 | — | plan? |
| Mar 27, 2017 PForm 4 → | Mar 28, 6:54 pm EDT | Adaptimmune Therapeutics PLCADAP | 1,190,476 | $4.20 | $4,999,999 | 6,149,377 | +24.0% | plan? |
| Nov 29, 2016 JForm 4 → | Dec 1, 8:45 pm EST | RESPONSE BIOMEDICAL CORPRBM | 5,885,343 | — | — | 0 | — | plan? |
| Jun 23, 2016 PForm 4 → | Jun 27, 6:51 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 1,000 | $12.98 | $12,983 | 5,379,349 | +0.02% | plan? |
| Jun 17, 2016 PForm 4 → | Jun 21, 7:00 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 38,383 | $12.75 | $489,192 | 5,378,349 | +0.72% | plan? |
| Jun 16, 2016 PForm 4 → | Jun 20, 5:44 pm EDT | RESPONSE BIOMEDICAL CORPRBM | 892,858 | $0.56 | $500,000 | 2,149,902 | +71.0% | plan? |
| Jun 14, 2016 PForm 4 → | Jun 16, 6:05 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 20,000 | $12.35 | $247,000 | 5,339,966 | +0.38% | plan? |
| Jun 9, 2016 PForm 4 → | Jun 13, 5:23 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 50,000 | $12.96 | $648,100 | 5,319,966 | +0.95% | plan? |
| May 20, 2016 PForm 4 → | May 25, 6:45 pm EDT | Adaptimmune Therapeutics PLCADAP | 1,712,400 | $10.42 | $17,849,568 | 29,753,404 | +6.11% | plan? late |
| May 20, 2016 PForm 4 → | May 24, 4:48 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 4,716 | $13.09 | $61,732 | 5,269,966 | +0.09% | plan? |
| May 18, 2016 PForm 4 → | May 20, 4:27 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 6,800 | $11.77 | $80,035 | 5,265,250 | +0.13% | plan? |
| Mar 29, 2016 PForm 4 → | Mar 29, 12:00 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 550,000 | $15.00 | $8,250,000 | 5,258,450 | +11.7% | plan? |
| Mar 29, 2016 CForm 4 → | Mar 29, 12:00 pm EDT | Corvus Pharmaceuticals, Inc.CRVS | 4,708,450 | — | — | 4,708,450 | — | plan? |
| Mar 24, 2016 AForm 4 → | Mar 28, 9:07 pm EDT | RESPONSE BIOMEDICAL CORPRBM | 37,058 | — | — | 96,884 | — | plan? |
| Jul 21, 2015 PForm 4 → | Jul 21, 7:03 pm EDT | ProNAi Therapeutics IncDNAI | 175,000 | $17.00 | $2,975,000 | 1,989,949 | +9.64% | plan? |
| Jul 21, 2015 CJForm 4 → | Jul 21, 7:03 pm EDT | ProNAi Therapeutics IncDNAI | 1,814,949 | $5.22 | $464,964 | 1,814,949 | — | plan? |
| May 19, 2015 AForm 4 → | May 21, 7:08 pm EDT | RESPONSE BIOMEDICAL CORPRBM | 10,511 | — | — | 59,826 | — | plan? |
| Mar 19, 2015 AForm 4 → | Mar 23, 8:17 pm EDT | RESPONSE BIOMEDICAL CORPRBM | 8,860 | — | — | 49,315 | — | plan? |